The head and neck district represents one of the most frequent sites of cancer, and the
percentage of metastases is very high in both loco-regional and distant areas. Prognosis …

Oral squamous cell carcinoma (OSCC) is a kind of malignant tumors with low survival rate
and prone to have early metastasis and recurrence. Cisplatin is an alkylating agent which …

Oral squamous cell carcinoma (OSCC) is the most common type of oral cancer; it involves
damage to oral epithelial cells due to accumulation of multiple genetic mutations in the cells …

While a large proportion of patients presenting with stage I and II squamous cell carcinoma
of the head and neck (SCCHN) will remain disease free after single modality treatment, the …

Background About 10 000 persons are diagnosed as having carcinoma of the oral cavity or
the throat in Germany every year. Squamous-cell carcinoma accounts for 95% of cases …

Background Oral cavity and oropharyngeal cancers are frequently described as part of a
group of oral cancers or head and neck cancer. Treatment of oral cavity cancer is generally …

Background To determine the safety, preliminary efficacy, pharmacokinetics, and
immunogenicity of a single cycle of RM-1929 photoimmunotherapy, an anti-EGFR antibody …

Chemotherapy has been reported to induce epithelial-mesenchymal transition (EMT) in
tumor cells, which is a critical step in the process of metastasis leading to cancer spreading …

Opinion statement Head and neck squamous cell carcinoma is now the 8th most common
cancer affecting men in the United States largely due to a rising epidemic of oropharynx …

The past several years have seen major advances in the use of systemic therapy for
treatment of patients with oral cancer. Systemic therapy refers to chemotherapy and …